Abstract
The evolution of cytochromes P450 has been thoroughly discussed in a number of reviews (Nebert and Gonzalez 1987; Nelson and Strobel 1987; Gonzalez and Nebert 1990). All cytochrome P450 proteins possess a non-covalently bound heme (protoporphyrin IX) and segment of 26 amino acids surrounding a cysteine that is highly conserved. This cysteine donates the thiolate fifth ligand to the heme iron. The amino acid environment surrounding the heme results in a typical cytochrome P450 Soret absorption band at around 450 nm when the iron is reduced by electrons and complexed with carbon monoxide. Any enzyme having these properties would be a “card-holding” member of the cytochrome P450 superfamily.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bale AE, Mitchell AL, Gonzalez FJ, McBride OW (1991) Localization of the CYP2F1 gene by multi-point linkage analysis and pulsed field gel electrophoresis. Genomics 10: 284–286
Brooks B, McBride OW, Dolphin CT, Farrall M, Scambler P, Gonzalez FJ, Idle JR (1988) The gene CYP3 encoding P450PCN1 (nifedipine oxidase) is tightly linked to the gene COLIA2 encoding collagen type I alpha on 7q21–q22.1. Am J Hum Genet 43: 280–284
Caporaso N, Landi MT, Vineis P (1991) Relevance of metabolic polymorphisms to human carcinogenesis: evolution of epidemiological evidence. Pharmacogenetics 1: 4–19
Dayhoff MO (1979) Atlas of protein sequence and structure, vol 5, suppl 3. National Biomedical Research Foundation, Silver Spring
Dover GA (1987) DNA turnover and the molecular clock. J Mol Evol 26: 47–58
Dover GA (1989) Slips, strings and species. Trends Genet 5: 100–102
Eichelbaum M, Gross AS (1990) The genetic polymorphism of debrisoquine/sparteine metabolism - clinical aspects. Pharmacol Ther 46: 377–394
Evans DAP (1989) N-acetyltransferase. Pharmacol Ther 47: 152–234
Gonzalez FJ (1991) Cytochrome P-450. In: Dulbecco R (ed) Encyclopedia of human biology, vol 2. Academic, New York, p 737
Gonzalez FJ, Nebert DW (1990) Evolution of the P450 gene superfamily: animal plant “warfare”, molecular drive and human genetic differences in drug oxidation. Trends Genet 6: 182–186
Gonzalez FJ, Matsunaga T, Nagata K, Meyer UA, Nebert DW, Pastekwa J, Kozak CA, Gillette J, Gelboin HV, Hardwick JP (1987) Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosome mapping, and molecular analysis of the DA rat polymorphism. DNA 6: 149–161
Gonzalez FJ, Crespi CL, Gelboin HV (1991) cDNA-expressed human cytochrome P450: a new age of molecular toxicology and human risk assessment. Mutat Res 247: 113–127
Matsunaga E, Zeugin T, Zanger UM, Aoyama T, Meyer UA, Gonzalez FJ (1990) Sequence requirements for cytochrome P450IID1 catalytic activity: a single amino acid change (IIe380 → Phe) specifically decreases Vmax of the enzyme for bufuralol but not debrisoquine hydroxylation. J Biol Chem 265: 17197–17201
Motulsky AG (1964) Pharmacogenetics. Prog Med Genet 3: 49–100
Nebert DW (1991) Proposed role of drug-metabolizing enzymes: regulation of steady-state levels of the ligands that effect growth, homeostasis, differentiation and neuroendocrine functions. Mol Endocrinol 5: 1203–1214
Nebert DW, Gonzalez FJ (1985) Cytochrome P-450 gene expression and regulation. Trends Pharmacol Sci 6: 160–164
Nebert DW, Gonzalez FJ (1987) P450 genes: structure, evolution and regulation. Annu Rev Biochem 56: 945–993
Nebert DW, Nelson DR (1991) P450 gene nomenclature based on evolution. Methods Enzymol 206: 3–11
Nebert DW, Weber WW (1990) Pharmacogenetics. In: Pratt WB, Taylor P (eds) Principles of drug action. The basis of pharmacology, 3rd edn. Churchill Livingstone, New York, pp 469–531
Nebert DW, Nelson DR, Feyereisen R (1989) Evolution of the cytochrome P450 genes. Xenobiotica 19: 1149–1160
Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fujii-Kuriyama Y, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ (1991) The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 10: 1–14
Nelson DR, Strobel HW (1987) Evolution of cytochrome P-450 proteins. Mol Biol Evol 4: 572–593
Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K, Nebert DW (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12: 1–70
Ruettinger RT, Wen LP, Fulco AJ (1989) Coding nucleotide, 5′ regulatory and deduced amino acid sequences of P-450BM3, a single peptide cytochrome P-450: NADPH-P-450 reductase from Bacillus megaterium. J Biol Chem 264: 10987–10995
Sneath PHA, Sokal RR (1973) Numerical taxonomy. Freeman, San Francisco.
Van Etten HD, Mathews DE, Mathews PS (1989) Phytoalexin detoxification: importance for the pathogenicity and practical implications. Annu Rev Phytopathol 27: 143–164.
Williams RT (1974) Inter-species variations on the metabolism of xenobiotics. Biochem Soc Trans 2: 359–377
Yamano S, Aoyama T, McBride OW, Hardwick JP, Gelboin HV, Gonzalez FJ (1989) Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7. Mol Pharmacol 35: 83–88
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gonzalez, F.J. (1993). Cytochrome P450 Evolution and Nomenclature. In: Schenkman, J.B., Greim, H. (eds) Cytochrome P450. Handbook of Experimental Pharmacology, vol 105. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77763-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-77763-9_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77765-3
Online ISBN: 978-3-642-77763-9
eBook Packages: Springer Book Archive